ヘリオスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/09/28 | 1,845 | 1,861 | 1,765 | 1,797 | -37 | -2% | 116,600 |
| 2018/09/27 | 1,845 | 1,861 | 1,821 | 1,834 | -5 | -0.3% | 85,300 |
| 2018/09/26 | 1,831 | 1,861 | 1,831 | 1,839 | +12 | +0.7% | 157,000 |
| 2018/09/25 | 1,785 | 1,849 | 1,781 | 1,827 | +81 | +4.6% | 238,300 |
| 2018/09/21 | 1,679 | 1,747 | 1,673 | 1,746 | +67 | +4% | 95,300 |
| 2018/09/20 | 1,689 | 1,703 | 1,662 | 1,679 | -25 | -1.5% | 47,000 |
| 2018/09/19 | 1,730 | 1,743 | 1,677 | 1,704 | -65 | -3.7% | 92,200 |
| 2018/09/18 | 1,762 | 1,784 | 1,741 | 1,769 | -9 | -0.5% | 43,700 |
| 2018/09/14 | 1,702 | 1,778 | 1,654 | 1,778 | +116 | +7% | 92,600 |
| 2018/09/13 | 1,663 | 1,690 | 1,625 | 1,662 | -18 | -1.1% | 64,400 |
| 2018/09/12 | 1,714 | 1,721 | 1,658 | 1,680 | -48 | -2.8% | 45,100 |
| 2018/09/11 | 1,718 | 1,739 | 1,715 | 1,728 | -17 | -1% | 32,300 |
| 2018/09/10 | 1,732 | 1,759 | 1,725 | 1,745 | +8 | +0.5% | 20,600 |
| 2018/09/07 | 1,743 | 1,745 | 1,695 | 1,737 | -18 | -1% | 60,500 |
| 2018/09/06 | 1,796 | 1,804 | 1,755 | 1,755 | -49 | -2.7% | 48,100 |
| 2018/09/05 | 1,795 | 1,810 | 1,782 | 1,804 | -7 | -0.4% | 44,800 |
| 2018/09/04 | 1,794 | 1,813 | 1,780 | 1,811 | +9 | +0.5% | 48,000 |
| 2018/09/03 | 1,820 | 1,820 | 1,774 | 1,802 | -21 | -1.2% | 75,500 |
| 2018/08/31 | 1,741 | 1,823 | 1,725 | 1,823 | +101 | +5.9% | 161,900 |
| 2018/08/30 | 1,749 | 1,755 | 1,722 | 1,722 | -19 | -1.1% | 64,300 |
| 2018/08/29 | 1,700 | 1,750 | 1,683 | 1,741 | +50 | +3% | 103,600 |
| 2018/08/28 | 1,784 | 1,784 | 1,663 | 1,691 | -79 | -4.5% | 98,400 |
| 2018/08/27 | 1,734 | 1,780 | 1,712 | 1,770 | +46 | +2.7% | 138,500 |
| 2018/08/24 | 1,717 | 1,730 | 1,693 | 1,724 | +11 | +0.6% | 71,400 |
| 2018/08/23 | 1,697 | 1,731 | 1,686 | 1,713 | +38 | +2.3% | 87,300 |
| 2018/08/22 | 1,651 | 1,696 | 1,629 | 1,675 | +31 | +1.9% | 94,300 |
| 2018/08/21 | 1,652 | 1,664 | 1,633 | 1,644 | -6 | -0.4% | 75,300 |
| 2018/08/20 | 1,610 | 1,717 | 1,610 | 1,650 | +73 | +4.6% | 183,600 |
| 2018/08/17 | 1,578 | 1,594 | 1,542 | 1,577 | +100 | +6.8% | 126,400 |
| 2018/08/16 | 1,500 | 1,500 | 1,476 | 1,477 | -23 | -1.5% | 31,800 |
| 2018/08/15 | 1,548 | 1,548 | 1,500 | 1,500 | -27 | -1.8% | 29,700 |
| 2018/08/14 | 1,522 | 1,542 | 1,518 | 1,527 | +7 | +0.5% | 21,400 |
| 2018/08/13 | 1,548 | 1,568 | 1,516 | 1,520 | -63 | -4% | 36,700 |
| 2018/08/10 | 1,555 | 1,616 | 1,550 | 1,583 | +40 | +2.6% | 114,000 |
| 2018/08/09 | 1,492 | 1,566 | 1,482 | 1,543 | +51 | +3.4% | 77,700 |
| 2018/08/08 | 1,482 | 1,506 | 1,454 | 1,492 | -8 | -0.5% | 100,000 |
| 2018/08/07 | 1,498 | 1,508 | 1,481 | 1,500 | +10 | +0.7% | 53,400 |
| 2018/08/06 | 1,489 | 1,499 | 1,480 | 1,490 | ±0 | ±0% | 29,400 |
| 2018/08/03 | 1,515 | 1,515 | 1,489 | 1,490 | -25 | -1.7% | 32,600 |
| 2018/08/02 | 1,508 | 1,521 | 1,503 | 1,515 | +2 | +0.1% | 39,400 |
| 2018/08/01 | 1,534 | 1,534 | 1,513 | 1,513 | -15 | -1% | 42,900 |
| 2018/07/31 | 1,512 | 1,529 | 1,511 | 1,528 | +17 | +1.1% | 60,500 |
| 2018/07/30 | 1,543 | 1,568 | 1,508 | 1,511 | -29 | -1.9% | 65,200 |
| 2018/07/27 | 1,540 | 1,544 | 1,521 | 1,540 | -1 | -0.1% | 32,600 |
| 2018/07/26 | 1,535 | 1,555 | 1,530 | 1,541 | -3 | -0.2% | 34,400 |
| 2018/07/25 | 1,551 | 1,553 | 1,530 | 1,544 | -6 | -0.4% | 34,300 |
| 2018/07/24 | 1,529 | 1,558 | 1,515 | 1,550 | +32 | +2.1% | 62,100 |
| 2018/07/23 | 1,527 | 1,527 | 1,516 | 1,518 | -3 | -0.2% | 20,200 |
| 2018/07/20 | 1,507 | 1,525 | 1,507 | 1,521 | +15 | +1% | 25,000 |
| 2018/07/19 | 1,527 | 1,527 | 1,501 | 1,506 | -14 | -0.9% | 29,700 |
1501～
1550
件表示中 / 2309件
類似銘柄と比較する
現在ご覧いただいている「ヘリオス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ヘリオス | 19,600円 | +395.9% | - | 0.00% | - | 5.45倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
| オンコリス | 70,300円 | +58.7% | - | 0.00% | - | 12.39倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
| Ｃｈｏｒｄｉａ | 24,900円 | - | - | 0.00% | - | 4.08倍 |
|
ＲＮＡ制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
市場注目の銘柄
チャート関連のコラム
